Unlock Breakthroughs - How AI Can Improve Productivity in Regulatory Affairs (On-Demand)

Member: $0 | NonMember: $25
Explore challenges experts face in adapting to rapidly evolving technologies of Generative AI. Gain insights from industry leaders, delve into real-life case studies, and discover the potential of AI in RA.

This is an On-demand recording from September 2023.


The emergence of Generative AI technologies like ChatGPT is set to impact every industry, whether they embrace it willingly or not. These advancements are rapidly reshaping our daily lives, and even experts in clinical, regulatory, and quality fields within the life sciences industry are finding it challenging to keep pace with the technological innovation and adapt to these transformative trends.

In this webinar, you will gain access to the most up-to-date insights shared by both technology leaders and industry experts. They will provide you with an understanding of how Generative AI is being approached in the realm of regulatory affairs. Additionally, you will explore the potential opportunities and challenges that arise when deploying generative AI in regulatory affairs through real-life case studies.

Registration Fees

Member: $0 | NonMember: $25

Learning Objectives

  • Learn about the fundamentals of Generative AI and where there’s still confusion
  • Understand the benefits of Generative AI on workflow augmentation, Regulatory Intelligence and Post Market Surveillance with real-life examples
  • Learn how experts are approaching Generative AI within their organizations while navigating the uncertainty

Audience Learning Level

Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher level activities.

Who Should Attend?

  • Regulatory affairs at all levels (VP, Director, Senior Manager, Manager, Lead, Specialist, Associate, Analyst, Coordinator)
  • Consultants
  • Medical writer, technical writer
  • Quality assurance
  • Risk management

Speakers

Michelle Wu

Michelle Wu
CEO & Co-founder, Nyquist AI

Daniel Schultz

Daniel Schultz
Principal, Medical Devices & Combination Products, Greenleaf Health

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.